Addus Homecare (NASDAQ:ADUS) had its price objective raised by Oppenheimer from $50.00 to $72.00 in a research report released on Wednesday morning, The Fly reports. The brokerage currently has an outperform rating on the stock.

Other analysts have also recently issued reports about the company. BidaskClub cut Addus Homecare from a strong-buy rating to a buy rating in a report on Friday, June 8th. ValuEngine raised Addus Homecare from a hold rating to a buy rating in a report on Wednesday, May 2nd. Zacks Investment Research cut Addus Homecare from a strong-buy rating to a hold rating in a report on Friday, April 13th. Robert W. Baird reaffirmed a hold rating and set a $65.00 price objective on shares of Addus Homecare in a report on Wednesday. Finally, Stephens upped their price objective on Addus Homecare from $67.00 to $75.00 and gave the stock an overweight rating in a report on Tuesday, August 7th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Addus Homecare currently has a consensus rating of Buy and a consensus target price of $68.00.

Shares of ADUS opened at $64.15 on Wednesday. The company has a market cap of $756.23 million, a PE ratio of 40.66, a PEG ratio of 2.17 and a beta of -0.39. Addus Homecare has a 1 year low of $30.95 and a 1 year high of $71.78. The company has a debt-to-equity ratio of 0.53, a quick ratio of 3.01 and a current ratio of 3.09.

Addus Homecare (NASDAQ:ADUS) last issued its quarterly earnings data on Tuesday, August 7th. The company reported $0.50 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.51 by ($0.01). The firm had revenue of $131.24 million for the quarter, compared to analysts’ expectations of $127.81 million. Addus Homecare had a return on equity of 10.45% and a net margin of 3.43%. equities analysts forecast that Addus Homecare will post 1.63 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Bank of New York Mellon Corp increased its position in shares of Addus Homecare by 6.2% during the 4th quarter. Bank of New York Mellon Corp now owns 89,846 shares of the company’s stock valued at $3,127,000 after purchasing an additional 5,265 shares during the last quarter. BlackRock Inc. increased its position in shares of Addus Homecare by 1.1% during the 4th quarter. BlackRock Inc. now owns 437,855 shares of the company’s stock valued at $15,238,000 after purchasing an additional 4,670 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Addus Homecare by 2.4% during the 4th quarter. Renaissance Technologies LLC now owns 72,800 shares of the company’s stock valued at $2,533,000 after purchasing an additional 1,700 shares during the last quarter. Deutsche Bank AG increased its position in shares of Addus Homecare by 51.6% during the 4th quarter. Deutsche Bank AG now owns 40,114 shares of the company’s stock valued at $1,393,000 after purchasing an additional 13,655 shares during the last quarter. Finally, Goldman Sachs Group Inc. bought a new position in shares of Addus Homecare during the 4th quarter valued at approximately $258,000. 90.89% of the stock is currently owned by hedge funds and other institutional investors.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Featured Story: Short Selling Stocks and Day Traders

The Fly

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.